Clinicians to offer insights into the key benefits of AUC-guided TDM for gentamicin, tobramycin, and amikacin
JUPITER, Fla.–(BUSINESS WIRE)–DoseMe:
| WHERE: | Register for the virtual event: From Theory to Practice: Maximizing Aminoglycoside Efficacy with the AUC-guided TDM |
|
| |
| WHEN: | US: Tuesday, September 19 at 8PM ET |
| AU: Wednesday, September 20 at 10AM AEST | |
|
| |
| WHAT: DoseMe, a leading provider of precision dosing software and creators of DoseMeRx and DoseMe Analytics, is hosting a free webinar on AUC-guided therapeutic drug monitoring (TDM) of aminoglycosides. Featured speaker Tony Lai, Senior Pharmacist, shares his first-hand experiences implementing AUC-dosing and top tips for making your own business case. New study results on how an Australian hospital improved dosing accuracy, reduced AKIs, and cut the number of labs in half in a pediatric population will also be presented. Participants can expect to: | |
| |
|
|
|
| WHO: |
|
| Tony Lai, Senior Pharmacist, Antimicrobial Stewardship/Infectious Diseases, at The Children’s Hospital at Westmead, Australia, has experience in an extensive range of Sydney hospitals spanning over 15 years in pediatrics and adults. His expert advisory editor roles include the Society of Hospital Pharmacy Australia (SHPA) Injectables Drugs Handbook, Australasian Neonatal Medicines Formulary (ANMF) and the upcoming Therapeutic Guidelines: Antibiotic. His research interest is dose optimization of antimicrobials and is currently a PhD candidate investigating liposomal amphotericin B therapeutic drug monitoring in children. | |
|
| |
| Sharmeen Roy, PharmD, BCPS, Chief Strategy and Science Officer, DoseMe, has over 20-years experience that spans pediatric clinical pharmacy, clinical research, and pharmacogenomics. She is passionate about leveraging technology to amplify the impact of the pharmacist. She received her Doctor of Pharmacy degree from the University of Illinois at Chicago and completed a Pediatric Specialty Pharmacotherapy Residency at Texas Children’s Hospital. | |
About DoseMe
DoseMe combines smart technology with science, leveraging clinically-validated PK/PD models, patient characteristics, drug concentrations, and genotype to accurately individualize a dose in seconds. The platform is HIPAA, ISO & FDA compliant and the only Bayesian dosing platform to be HITRUST CSF certified. For more information on successful applications of its products, DoseMeRx and DoseMe Analytics, visit https://doseme-rx.com/success-stories
Contacts
Alison Guzzio
aburnsguzzio@gmail.com
484-459-3243
HONG KONG SAR - EQS Newswire - 23 December 2024 - Novautek Autonomous Driving Limited…
JAKARTA, INDONESIA - Media OutReach Newswire - 23 December 2024 - V-GREEN and PT Xanh…
Increase in opportunities predicted for high-speed optical transceivers and miniaturized connectivity solutions to address data-intensive…
HONG KONG SAR - Media OutReach Newswire - 23 December 2024 - DYXnet, a wholly-owned…
CAIRO, EGYPT - Media OutReach Newswire - 23 December 2024 - Eand, Novo Nordisk, BSH,…
Trend Vision One™ – Email and Collaboration Security is a critical part of Trend’s centralized…